Association between deprescribing from polypharmacy and functional recovery and home discharge among older patients with sarcopenia after stroke
Nutrition · 2023
DOI: 10.1016/j.nut.2023.112040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition, 2023. Verfasst von Eiji Kose und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Juntendo University Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Deprescriptions, Stroke Rehabilitation, Stroke. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Themen: Medikationssicherheit, Schlaganfall
Abstract (Originalsprache)
OBJECTIVE: Evidence regarding the association between deprescribing from polypharmacy and outcomes in the convalescent rehabilitation setting is rare. The aim of this study was to assess the association between deprescribing from polypharmacy and functional recovery and home discharge in older patients with sarcopenia after stroke. METHODS: This retrospective cohort study was conducted at a convalescent rehabilitation hospital from January 2015 to December 2021. Among newly admitted patients in the convalescent rehabilitation ward who had experienced a stroke, patients aged ≥65 y with sarcopenia at admission and who were using at least five medications were included. Sarcopenia was diagnosed according to hand-grip strength and skeletal muscle mass index following the criteria of the Asian Working Group for Sarcopenia 2019. The primary outcome measures were functional independence-measured motor activity (FIM-motor) at discharge and home discharge. Multiple regression analysis was used to determine whether deprescribing from polypharmacy at admission was independently associated with rehabilitation outcomes. RESULTS: Among the 264 patients with polypharmacy, 153 patients (mean age, 81.1 y; 46.4% males) were diagnosed with sarcopenia and included in the analysis. Of them, 56 (36.6%) were deprescribed from polypharmacy. Deprescribing from polypharmacy was independently associated with FIM-motor at discharge (β, 0.137; P = 0.017) and home discharge (odds ratio, 1.393; P = 0.002). CONCLUSIONS: Because no effective pharmacotherapy for sarcopenia has been established, the novel findings of this study may be useful in the pharmacotherapy for older patients with sarcopenia after stroke. Deprescribing from polypharmacy on admission was positively associated with functional status at discharge and home discharge in older patients with sarcopenia after stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Juntendo University Hospital, Tokyo, Japan.
- Department of Pharmacy, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
- Center for Sarcopenia and Malnutrition Research, Kumamoto Rehabilitation Hospital, Kumamoto, Japan. Electronic address: hanley.belfus@gmail.com.
Zitieren
APA
Kose, E., Matsumoto, A., & Yoshimura, Y. (2023). Association between deprescribing from polypharmacy and functional recovery and home discharge among older patients with sarcopenia after stroke. Nutrition. https://doi.org/10.1016/j.nut.2023.112040
Vancouver
Kose E, Matsumoto A, Yoshimura Y. Association between deprescribing from polypharmacy and functional recovery and home discharge among older patients with sarcopenia after stroke. Nutrition. 2023. doi:10.1016/j.nut.2023.112040
BibTeX
@article{Kose2023,
author = {Kose, Eiji and Matsumoto, Ayaka and Yoshimura, Yoshihiro},
title = {Association between deprescribing from polypharmacy and functional recovery and home discharge among older patients with sarcopenia after stroke},
journal = {Nutrition},
year = {2023},
doi = {10.1016/j.nut.2023.112040}
}
EUVIMED